Philip L. Johnson's Insider Trades & SAST Disclosures

Philip L. Johnson's most recent trade in Jazz Pharmaceuticals plc was a trade of 1,149 Ordinary Shares done at an average price of $139.0 . Disclosure was reported to the exchange on March 5, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Jazz Pharmaceuticals plc
Philip L. Johnson EVP & Chief Financial Officer Sale or transfer of securities back to the company at price $ 138.95 per share. 05 Mar 2025 1,149 50,060 (0%) 0% 139.0 159,654 Ordinary Shares
Jazz Pharmaceuticals plc
Philip L. Johnson EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 15,407 43,505 (0%) 0% 0 Ordinary Shares
Jazz Pharmaceuticals plc
Philip L. Johnson EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2025 7,704 51,209 (0%) 0% 0 Ordinary Shares
Jazz Pharmaceuticals plc
Philip L. Johnson EVP & Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 15,932 15,932 (0%) 0% 0 Ordinary Shares
Jazz Pharmaceuticals plc
Philip L. Johnson EVP & Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 119.65 per share. 01 Mar 2024 12,000 27,932 (0%) 0% 119.7 1,435,800 Ordinary Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades